Related Experiment Video
Updated: Jul 7, 2026
Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells
Published on: May 9, 2025
Quantitative measurement of epidermal growth factor receptor-mitogen-activated protein kinase signal transduction
Christine Rauh-Adelmann1, John M Moskow, James R Graham
1Epitome Biosystems, Waltham, MA 02453, USA.
Abstract:
Aberrant epidermal growth factor receptor (EGFR, ErbB1) signaling is implicated in cell transformation, motility, and invasion in a variety of cell types, and EGFR is the target of several anticancer drugs. However, the kinetics of EGFR signaling and the individual contributions of site-specific phosphorylation events remain largely unknown. A peptide-based, multiplex immunoassay approach was developed to simultaneously measure both total and phosphorylated protein in a single sample. The approach involves the proteolytic digestion of proteins prior to the isolation and quantitation of site-specific phosphorylation events within an individual protein. Quantitation of phosphorylated and total proteins, in picomolar to nanomolar concentrations, were interpolated from standard curves generated with synthetic peptides that correspond to the peptide targets used in the immunoassays. In this study, a bead-based, nine-plex immunoassay measuring total and phosphorylated protein was constructed to measure temporal, site-specific phosphorylation of key members of the EGFR pathway (ErbB1 receptor, MEK1, MEK2, ERK1, and ERK2) in A431 cells stimulated with epidermal growth factor. The effect of MEK inhibition on this pathway was determined using a known MEK kinase inhibitor, SL327. The results reported herein are the first quantitative measurements of site-specific phosphorylation events and total proteins in a single sample, at the same time representing a new paradigm for standardized protein and phosphorylation analysis using multiplexed, peptide-based, sandwich immunoassays.
Insights
This study introduces a novel multiplex immunoassay to quantify both total and phosphorylated proteins simultaneously. This method advances the understanding of epidermal growth factor receptor (EGFR) signaling kinetics and phosphorylation events.
Area of Science:
- Biochemistry
- Cell Biology
- Molecular Signaling
Background:
- Aberrant epidermal growth factor receptor (EGFR) signaling drives cancer progression, but its kinetics and site-specific phosphorylation remain poorly understood.
- EGFR is a key target for anticancer therapies, necessitating a deeper understanding of its signaling pathways.
- Current methods lack the ability to simultaneously measure total and phosphorylated proteins, hindering detailed kinetic analysis.
Purpose of the Study:
- To develop and validate a novel peptide-based, multiplex immunoassay for simultaneous quantification of total and phosphorylated proteins.
- To investigate the temporal, site-specific phosphorylation dynamics of key epidermal growth factor receptor (EGFR) pathway components.
- To assess the impact of MEK inhibition on EGFR pathway phosphorylation using the developed assay.
Main Methods:
- A bead-based, nine-plex immunoassay was developed using proteolytic digestion and synthetic peptide standards.
- The assay simultaneously measured total and phosphorylated levels of EGFR (ErbB1), MEK1, MEK2, ERK1, and ERK2.
- A431 cells stimulated with epidermal growth factor were analyzed, with and without MEK inhibitor SL327.
Main Results:
- The study successfully quantified site-specific phosphorylation events and total protein levels in a single sample.
- Temporal phosphorylation dynamics of the EGFR pathway components were elucidated.
- The assay demonstrated the ability to measure the effects of kinase inhibition on pathway signaling.
Conclusions:
- The developed multiplex immunoassay represents a new paradigm for standardized protein and phosphorylation analysis.
- This method enables quantitative measurements of site-specific phosphorylation events and total proteins simultaneously.
- The findings provide crucial insights into the kinetics of EGFR signaling and its regulation.
